Geneva tells distributors to hold generic captopril pending resolution of Bristol hearing.
Executive Summary
GENEVA INSTRUCTING DISTRIBUTORS TO HOLD GENERIC CAPTOPRIL pending the outcome of a hearing with Bristol-Myers Squibb over a temporary restraining order issued by a Newark federal court judge Nov. 11. The TRO came one day after the Ciba-Geigy subsidiary began shipping the generic version of Bristol's ACE inhibitor Capoten following the Nov. 9 approval of Geneva's ANDA ("The Pink Sheet" Nov. 13, T&G-1).